Kolshus E, Ryan KM, Blackshields G, Smyth P, Sheils O, McLoughlin DM. Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression. Acta Psychiatr Scand. 2017;136:594–606.
Philip NS, Carpenter LL, Tyrka AR, Price LH. Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opin Pharmacother. 2010;11:709–22.
Fries GR, Zhang W, Benevenuto D, Quevedo J. MicroRNAs in major depressive disorder. Adv Exp Med Biol. 2019;1118:175–90.
Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Prim. 2016;2:16065.
Dattani S, Rodés-Guirao L, Ritchie H, Roser M. Mental health. Our World in Data. 2023. Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/mental-health.
Lin C-Y, Hung S-Y, Chen H-T, Tsou H-K, Fong Y-C, Wang S-W, et al. Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells. Biochem Pharmacol. 2014;91:522–33.
Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:363.
Faust K, Vajkoczy P, Xi B, Harnack D. The effects of deep brain stimulation of the subthalamic nucleus on vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in a rat model of Parkinson’s disease. Stereotact Funct Neurosurg. 2021;99:256–66.
Nøhr AK, Lindow M, Forsingdal A, Demharter S, Nielsen T, Buller R, et al. A large-scale genome-wide gene expression analysis in peripheral blood identifies very few differentially expressed genes related to antidepressant treatment and response in patients with major depressive disorder. Neuropsychopharmacology. 2021;46:1324–32.
Ma Y, Rosenheck R, Ye B, Fan N, He H. Effectiveness of electroconvulsive therapy in patients with “less treatment‐resistant” depression by the Maudsley Staging Model. Brain Behav. 2020;10:e01654.
Cano M, Martínez-Zalacaín I, Bernabéu-Sanz Á, Contreras-Rodríguez O, Hernández-Ribas R, Via E, et al. Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study. Transl Psychiatry. 2017;7:e1023.
Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry. 2014;4:33–54.
Leaver AM, Espinoza R, Wade B, Narr KL. Parsing the network mechanisms of electroconvulsive therapy. Biol Psychiatry. 2022;92:193–203.
Broderick JA, Zamore PD. MicroRNA therapeutics. Gene Ther. 2011;18:1104–10.
Mullany LE, Herrick JS, Wolff RK, Stevens JR, Samowitz W, Slattery ML. MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases. Genes Chromosomes Cancer. 2018;57:192–202.
Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5–20.
Dwivedi Y. MicroRNAs in depression and suicide: recent insights and future perspectives. J Affect Disord. 2018;240:146–54.
Zhou L, Zhu Y, Chen W, Tang Y. Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response. J Affect Disord. 2021;286:80–6.
Bayraktar R, Van Roosbroeck K, Calin GA. Cell‐to‐cell communication: microRNAs as hormones. Mol Oncol. 2017;11:1673–86.
Jose AM. Movement of regulatory RNA between animal cells. Genesis. 2015;53:395–416.
Mustapic M, Eitan E, Werner JK, Berkowitz ST, Lazaropoulos MP, Tran J, et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11:278.
Goldberg M, Islam MR, Kerimoglu C, Lancelin C, Gisa V, Burkhardt S, et al. Exercise as a model to identify microRNAs linked to human cognition: a role for microRNA-409 and microRNA-501. Transl Psychiatry. 2021;11:1–13.
O’Connor RM, Dinan TG, Cryan JF. Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Mol Psychiatry. 2012;17:359–76.
Gururajan A, Naughton ME, Scott KA, O’Connor RM, Moloney G, Clarke G, et al. MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c. Transl Psychiatry. 2016;6:e862.
Roy B, Yoshino Y, Allen L, Prall K, Schell G, Dwivedi Y. Exploiting circulating micrornas as biomarkers in psychiatric disorders. Mol Diagn Ther. 2020;24:279–98.
Borza T, Engedal K, Bergh S, Benth JŠ, Selbæk G. The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients. BMC Psychiatry. 2015;15:191.
Kruse JL, Olmstead R, Hellemann G, Wade B, Jiang J, Vasavada MM, et al. Inflammation and depression treatment response to electroconvulsive therapy: sex-specific role of interleukin-8. Brain Behav Immun. 2020;89:59–66.
Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25.
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 2008;9:559.
Risso D, Ngai J, Speed TP, Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014;32:896–902.
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
Islam MR, Kaurani L, Berulava T, Heilbronner U, Budde M, Centeno TP, et al. A microRNA signature that correlates with cognition and is a target against cognitive decline. EMBO Mol Med. 2021;13:e13659.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.
Gutiérrez-Sacristán A, Grosdidier S, Valverde O, Torrens M, Bravo À, Piñero J, et al. PsyGeNET: a knowledge platform on psychiatric disorders and their genes. Bioinformatics. 2015;31:3075–7.
Cuomo-Haymour N, Kaiser S, Hartmann-Riemer M, Guetter K, Klaus F, Cathomas F, et al. Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder. Biomark Neuropsychiatry. 2022;6:100049.
Pirnia T, Joshi SH, Leaver AM, Vasavada M, Njau S, Woods RP, et al. Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex. Transl Psychiatry. 2016;6:e832.
Inta D, Lima-Ojeda JM, Lau T, Tang W, Dormann C, Sprengel R, et al. Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS ONE. 2013;8:e69869.
Järventausta K, Sorri A, Kampman O, Björkqvist M, Tuohimaa K, Hämäläinen M, et al. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. Acta Psychiatr Scand. 2017;135:87–92.
Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017;64:367–83.
Muhammad RN, Ahmed LA, Abdul Salam RM, Ahmed KA, Attia AS. Crosstalk among NLRP3 inflammasome, ETBR signaling, and miRNAs in stress-induced depression-like behavior: a modulatory role for SGLT2 inhibitors. Neurotherapeutics. 2021;18:2664–81.
Borrione L, Bellini H, Razza LB, Avila AG, Baeken C, Brem A-K, et al. Precision non-implantable neuromodulation therapies: a perspective for the depressed brain. Braz J Psychiatry. 2020;42:403–19.
van Diermen L, van den Ameele S, Kamperman AM, Sabbe BCG, Vermeulen T, Schrijvers D, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry. 2018;212:71–80.
van Diermen L, Poljac E, Van der Mast R, Plasmans K, Van den Ameele S, Heijnen W, et al. Toward targeted ECT: the interdependence of predictors of treatment response in depression further explained. J Clin Psychiatry. 2020;82:20m13287.
Belge J-B, van Diermen L, Sabbe B, Parizel P, Morrens M, Coppens V, et al. Inflammation, hippocampal volume, and therapeutic outcome following electroconvulsive therapy in depressive patients: a pilot study. Neuropsychobiology. 2020;79:222–32.
Blanco I, Conant K. Extracellular matrix remodeling with stress and depression: studies in human, rodent and zebrafish models. Eur J Neurosci. 2021;53:3879–88.
Schoenfeld TJ, McCausland HC, Morris HD, Padmanaban V, Cameron HA. Stress and loss of adult neurogenesis differentially reduce hippocampal volume. Biol Psychiatry. 2017;82:914–23.
Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingström A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043–9.
Ousdal OT, Brancati GE, Kessler U, Erchinger V, Dale AM, Abbott C, et al. The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: what have we learned, and where do we go? Biol Psychiatry. 2022;91:540–9.
Argyelan M, Oltedal L, Deng Z-D, Wade B, Bikson M, Joanlanne A, et al. Electric field causes volumetric changes in the human brain. eLife. 2019;8:e49115.
Xu Y, Liu H, Li F, Sun N, Ren Y, Liu Z, et al. A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. J Affect Disord. 2010;127:332–6.
Gorinski N, Bijata M, Prasad S, Wirth A, Abdel Galil D, Zeug A, et al. Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors. Nat Commun. 2019;10:3924.
Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012;6:369–88.
Keller MB. Issues in treatment-resistant depression. J Clin Psychiatry. 2005;66:5–12.
Jiao P, Wang X-P, Luoreng Z-M, Yang J, Jia L, Ma Y, et al. miR-223: an effective regulator of immune cell differentiation and inflammation. Int J Biol Sci. 2021;17:2308–22.
Ali S, Khan MS, Wani JA, Faiz S, Rehman MU, Majid S, et al. Chapter 13 – miRNAs: the genetic regulators of immunity. In: Rehman MU, Arafah A, Ali MDN, Ali S, editors. A Molecular Approach to Immunogenetics, Academic Press; 2022. p. 299–325. https://doi.org/10.1016/B978-0-323-90053-9.00003-8, https://www.sciencedirect.com/science/article/pii/B9780323900539000038.
Bauernfeind F, Rieger A, Schildberg FA, Knolle PA, Schmid-Burgk JL, Hornung V. NLRP3 inflammasome activity is negatively controlled by miR-223. J Immunol. 2012;189:4175–81.
Neudecker V, Brodsky KS, Clambey ET, Schmidt EP, Packard TA, Davenport B, et al. Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice. Sci Transl Med. 2017;9:eaah5360.
Yuan S, Wu Q, Wang Z, Che Y, Zheng S, Chen Y, et al. miR-223: an immune regulator in infectious disorders. Front Immunol. 2021;12:781815.
Qu H, Liu R, Chen J, Zheng L, Chen R. Aerobic exercise inhibits CUMS-depressed mice hippocampal inflammatory response via activating hippocampal miR-223/TLR4/MyD88-NF-κB pathway. Int J Environ Res Public Health. 2020;17:2676.
Swanson KV, Deng M, Ting JP-Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–89.
Alcocer-Gómez E, de Miguel M, Casas-Barquero N, Núñez-Vasco J, Sánchez-Alcazar JA, Fernández-Rodríguez A, et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun. 2014;36:111–7.
Iwata M, Ota KT, Duman RS. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun. 2013;31:105–14.
Tian H, Li G, Xu G, Liu J, Wan X, Zhang J, et al. Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder. Eur Arch Psychiatry Clin Neurosci. 2021;271:475–85.
Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry. 2008;64:484–90.
Roohi E, Jaafari N, Hashemian F. On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflammation. 2021;18:45.
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234–56.
Lee C-H, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. 2019;10:1696.
Gay F, Romeo B, Martelli C, Benyamina A, Hamdani N. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a meta-analysis. Psychiatry Res. 2021;297:113735.
Dahl J, Ormstad H, Aass HCD, Sandvik L, Malt UF, Andreassen OA. Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels. Acta Psychiatr Scand. 2016;134:40–47.
Moreira FP, Cardoso T, de A, Mondin TC, Souza LD, de M, et al. The effect of proinflammatory cytokines in cognitive behavioral therapy. J Neuroimmunol. 2015;285:143–6.
Yrondi A, Sporer M, Péran P, Schmitt L, Arbus C, Sauvaget A. Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review. Brain Stimul. 2018;11:29–51.
Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19:183–8.
Das S, Halushka MK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol. 2015;24:199–206.
Xu B, Zhang Y, Du X-F, Li J, Zi H-X, Bu J-W, et al. Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity. Cell Res. 2017;27:882–97.
Men Y, Yelick J, Jin S, Tian Y, Chiang MSR, Higashimori H, et al. Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS. Nat Commun. 2019;10:4136.
Nogueras-Ortiz CJ, Mahairaki V, Delgado-Peraza F, Das D, Avgerinos K, Eren E, et al. Astrocyte- and neuron-derived extracellular vesicles from Alzheimer’s disease patients effect complement-mediated neurotoxicity. Cells. 2020;9:1618.
Badhwar A, Haqqani AS. Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer’s disease. Alzheimers Dement. 2020;12:e12001.
Brymer KJ, Romay-Tallon R, Allen J, Caruncho HJ, Kalynchuk LE. Exploring the potential antidepressant mechanisms of TNFα antagonists. Front Neurosci. 2019;13:98.
Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31–41.
Ye L, Xiao X, Xu Y, Zheng C, Chen S, Luo T, et al. Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions. Neuropharmacology. 2022;208:108984.